Current browse context:
q-bio.CB
Change to browse by:
References & Citations
Quantitative Biology > Cell Behavior
Title: Novel therapeutic targets in chronic myeloid leukaemia through a discrete time discrete Markov chain model of BCR-ABL1 interactions
(Submitted on 22 Feb 2020)
Abstract: Chronic Myeloid Leukaemia (CML) is a blood-derived proliferative disorder, which is highly associated to a translocation of chromosomes 9 and 22 or the creation of Philadelphia chromosome Ph(+) cases, inducing the synthesis of a chimeric fusion protein, namely BCR-ABL1 (Breakpoint Cluster Region-Abelson 1 chimeric protein), which is known for driving the pathophysiology of the disease, however variants of CML are also recognized as CML Ph(-), these nonetheless account for a small percentage of the overall CML patients; posing thus the question whether BCR-ABL1 fusion protein is required for the whole of the pathophysiology of CML. Hereof, through a stochastic description, a discrete time discrete Markov chain depicts the various protein-protein interactions of BCR-ABL1 to better understand signalling pathways and time-dependent evolution of these pathways, as well as to provide prospective therapeutic protein targets to improve both the specificity of the treatment and the life-expectancy of the patients.
Submission history
From: Alfonso Vivanco Lira [view email][v1] Sat, 22 Feb 2020 05:29:04 GMT (896kb)
Link back to: arXiv, form interface, contact.